Patent details

EP3529359 Title: TUMOR INFILTRATING LYMPHOCYTES FOR USE IN THERAPY

Basic Information

Publication number:
EP3529359
PCT Application Number:
US2017057228
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP178617924
PCT Publication Number:
WO2018075664
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TUMOR INFILTRATING LYMPHOCYTES FOR USE IN THERAPY
French Title of Invention:
LYMPHOCYTES INFILTRANT LES TUMEURS POUT UTILISATION EN THÉRAPIE
German Title of Invention:
TUMORINFILTRIERENDE LYMPHOZYTEN ZUR VERWENDUNG IN DER THERAPIE
SPC Number:

Dates

Filing date:
18/10/2017
Grant date:
13/12/2023
EP Publication Date:
28/08/2019
PCT Publication Date:
26/04/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/12/2023
EP B1 Publication Date:
13/12/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/10/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/12/2023
 
 

Name:
Intima Bioscience, Inc.
Address:
3 Columbus Circle, New York, New York 10019, United States (US)

Name:
Regents of the University of Minnesota
Address:
600 McNamara Alumni Center 200 Oak Street S.E., Minneapolis, MN 55455-2020, United States (US)

Name:
The United States of America, as represented by the Secretary, Department of Health and Human Services
Address:
Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, MSC 7660,, Bethesda, MD 20892-7660, United States (US)

Inventor

1

Name:
RESTIFO, Nicholas P.
Address:
United States (US)

2

Name:
CHOUDHRY, Modassir
Address:
United States (US)

3

Name:
PALMER, Douglas C.
Address:
United States (US)

4

Name:
WEBBER, Beau
Address:
United States (US)

5

Name:
MORIARITY, Branden
Address:
United States (US)

6

Name:
ROSENBERG, Steven A.
Address:
United States (US)

Priority

1

Priority Number:
201662409651 P
Priority Date:
18/10/2016
Priority Country:
United States (US)

2

Priority Number:
201762452244 P
Priority Date:
30/01/2017
Priority Country:
United States (US)

Classification

IPC classification:
A61K 35/17; A61P 35/02; A61P 35/00; A61P 31/12; C07K 14/715; C07K 14/705; C07K 14/47; C12N 9/22; C12N 15/113; A61P 31/00;

Publication

European Patent Bulletin

1

Issue number:
202350
Publication date:
13/12/2023
Description:
Grant (B1)

2

Issue number:
202401
Publication date:
03/01/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/04/2025
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages